Prasugrel product-specific bioequivalence guidance

  • Email
  • Help
Current effective version

Adopted guideline

Currently under revision - see below

Reference numberEMA/CHMP/158772/2016
Published27/05/2016
Effective from01/11/2016
KeywordsBioequivalence, generics, prasugrel
DescriptionThis document provides product-specific guidance on the demonstration of the bioequivalence of prasugrel.
Abbreviations
  • BCS Classification: Biopharmaceutics Classification System
  • AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
  • AUC0-72: area under the plasma concentration curve from administration to last observed concentration at 72 hours
  • Cmax: maximum plasma concentration


Document history

Revision 1

In progress

Adopted guideline

Published: 03/08/2017

Deadline for comments: 31/10/2017

 

First version

Current version

Adopted guideline


 

Overview of comments


 

Draft guideline

In operation: 01/11/2016


 

Published: 07/04/2016


 

Published: 15/07/2015


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
1 ratings
0 ratings
    

Tell us more